161 related articles for article (PubMed ID: 28640360)
41. Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment.
Resnicow K; Abrahamse P; Tocco RS; Hawley S; Griggs J; Janz N; Fagerlin A; Wilson A; Ward KC; Gabram SG; Katz S
BMC Med Inform Decis Mak; 2014 Dec; 14():110. PubMed ID: 25476986
[TBL] [Abstract][Full Text] [Related]
42. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
Osborne C; Ostir GV; Du X; Peek MK; Goodwin JS
Breast Cancer Res Treat; 2005 Sep; 93(1):41-7. PubMed ID: 16184457
[TBL] [Abstract][Full Text] [Related]
43. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ
Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391
[TBL] [Abstract][Full Text] [Related]
44. Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment.
Hamilton AS; Hofer TP; Hawley ST; Morrell D; Leventhal M; Deapen D; Salem B; Katz SJ
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2022-9. PubMed ID: 19549806
[TBL] [Abstract][Full Text] [Related]
45. Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty.
Resnicow K; Patel MR; Mcleod MC; Katz SJ; Jagsi R
Breast Cancer Res Treat; 2019 Jan; 173(1):31-36. PubMed ID: 30259283
[TBL] [Abstract][Full Text] [Related]
46. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
[TBL] [Abstract][Full Text] [Related]
47. Treatment decision-making among older women with breast cancer.
Ciambrone D
J Women Aging; 2006; 18(4):31-47. PubMed ID: 17200062
[TBL] [Abstract][Full Text] [Related]
48. Determinants of participation in treatment decision-making by older breast cancer patients.
Maly RC; Umezawa Y; Leake B; Silliman RA
Breast Cancer Res Treat; 2004 Jun; 85(3):201-9. PubMed ID: 15111757
[TBL] [Abstract][Full Text] [Related]
49. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study.
Alderman AK; Hawley ST; Janz NK; Mujahid MS; Morrow M; Hamilton AS; Graff JJ; Katz SJ
J Clin Oncol; 2009 Nov; 27(32):5325-30. PubMed ID: 19805680
[TBL] [Abstract][Full Text] [Related]
50. An informed decision? Breast cancer patients and their knowledge about treatment.
Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
[TBL] [Abstract][Full Text] [Related]
51. Breast Cancer Surgery Decision-Making and African-American Women.
Schubart JR; Farnan MA; Kass RB
J Cancer Educ; 2015 Sep; 30(3):497-502. PubMed ID: 25200948
[TBL] [Abstract][Full Text] [Related]
52. A peer-led decision support intervention improves decision outcomes in black women with breast cancer.
Sheppard VB; Wallington SF; Willey SC; Hampton RM; Lucas W; Jennings Y; Horton S; Muzeck N; Cocilovo C; Isaacs C
J Cancer Educ; 2013 Jun; 28(2):262-9. PubMed ID: 23576067
[TBL] [Abstract][Full Text] [Related]
53. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
[TBL] [Abstract][Full Text] [Related]
54. Development of decision-support intervention for Black women with breast cancer.
Sheppard VB; Williams KP; Harrison TM; Jennings Y; Lucas W; Stephen J; Robinson D; Mandelblatt JS; Taylor KL
Psychooncology; 2010 Jan; 19(1):62-70. PubMed ID: 19267384
[TBL] [Abstract][Full Text] [Related]
55. Family involvement for breast cancer decision making among Chinese-American women.
Lee SK; Knobf MT
Psychooncology; 2016 Dec; 25(12):1493-1499. PubMed ID: 26374698
[TBL] [Abstract][Full Text] [Related]
56. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
Friese CR; Li Y; Bondarenko I; Hofer TP; Ward KC; Hamilton AS; Deapen D; Kurian AW; Katz SJ
Cancer; 2017 Jan; 123(1):43-51. PubMed ID: 27775837
[TBL] [Abstract][Full Text] [Related]
58. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
59. Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
Katz SJ; Ward KC; Hamilton AS; Mcleod MC; Wallner LP; Morrow M; Jagsi R; Hawley ST; Kurian AW
J Clin Oncol; 2018 Apr; 36(12):1218-1224. PubMed ID: 29528794
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.
Friese CR; Pini TM; Li Y; Abrahamse PH; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Hawley ST; Katz SJ; Griggs JJ
Breast Cancer Res Treat; 2013 Apr; 138(3):931-9. PubMed ID: 23542957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
